| Title : Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical beta-Blockers - Baker_2020_ACS.Pharmacol.Transl.Sci_3_737 |
| Author(s) : Baker JG , Fromont C , Bruder M , Thompson KSJ , Kellam B , Hill SJ , Gardiner SM , Fischer PM |
| Ref : ACS Pharmacol Transl Sci , 3 :737 , 2020 |
| Abstract : Baker_2020_ACS.Pharmacol.Transl.Sci_3_737 |
| ESTHER : Baker_2020_ACS.Pharmacol.Transl.Sci_3_737 |
| PubMedSearch : Baker_2020_ACS.Pharmacol.Transl.Sci_3_737 |
| PubMedID: 32832874 |
Baker JG, Fromont C, Bruder M, Thompson KSJ, Kellam B, Hill SJ, Gardiner SM, Fischer PM (2020)
Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical beta-Blockers
ACS Pharmacol Transl Sci
3 :737
Baker JG, Fromont C, Bruder M, Thompson KSJ, Kellam B, Hill SJ, Gardiner SM, Fischer PM (2020)
ACS Pharmacol Transl Sci
3 :737